In8 Bio, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
INAB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Empire State Building, 350 5 Th Avenue, Suite 5330, New York, New York

Insiders trading volume in the past year

In8 Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher 10%+ Owner $8.86 M Dec 13, 2023
Leslie W. Kreis 10%+ Owner $8.86 M Dec 13, 2023
William Tai-Wei Ho PRESIDENT AND CEO, Director, 10%+ Owner $2.61 M +$25 K +0.97% Feb 7, 2024
Peter C. Brandt Director $381 K Jun 12, 2024
Alan S. Roemer Director $163 K Jun 12, 2024
Lawrence Lamb Evp And Cso $104 K Feb 7, 2024
Corinne Epperly Director $84.4 K Jun 12, 2024
Patrick McCall Chief Financial Officer $27.6 K +$1.03 K +3.88% Feb 7, 2024
Kate Rochlin Chief Operating Officer $18.1 K Feb 7, 2024
Trishna Goswami Chief Medical Officer $6.93 K Feb 7, 2024
Jeremy R. Graff Director $4.69 K +$2.38 K +103% Jun 12, 2024
Bios Equity Partners, LP 10%+ Owner Aug 13, 2021
Bios Clinical Opportunity Fund, LP 10%+ Owner Dec 13, 2023
Emily Fairbairn Director Jun 12, 2024
Melissa Beelen VP, Clinical Operation Jul 29, 2021
Luba Greenwood Director Jun 12, 2024
Travis Whitfill Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for In8 Bio, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership